Aung Naing, Khaldoun Almhanna, Joaquina Celebre Baranda, Vladimir Galvao, Elena Garralda, Emiliano Calvo, Marloes Van Dongen, Ferry Eskens, Jonathan Cohen, Tamar Beller, Fatima Menas, Chen Zhu, Keisuke Tada, Helene Guillemin-Paveau, Victorine Koch, Winston Huh, Giovanni Abbadessa, Raymond P. Perez, Martin Gutierrez. "Initial safety and efficacy results from a first-in-human, phase 1/2 study of SAR445877, an anti-PD-1/IL-15 fusion protein, for patients with advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2572